Multimedia Available: Early Treatment with Bayer Drug Can Drastically Lower the Risk of Diabetes and Cardiovascular Disease.Business Editors & Health/Medical Writers ADVISORY...for Wednesday (Nov. 27) NOTE TO EDITORS: Multimedia Assets Available With This Story Include Logos, Text News Releases, Video --(BUSINESS WIRE) Patients with impaired glucose tolerance Impaired Glucose Tolerance (IGT) is a pre-diabetic state of dysglycemia, that is associated with insulin resistance and increased risk of cardiovascular pathology. IGT may precede type 2 diabetes mellitus by many years. IGT is also a risk factor for mortality. who receive treatment with acarbose acarbose /acar·bose/ (a´kahr-bos) an a inhibitor used in treatment of type 2 diabetes mellitus. acarbose, n brand name: Precose, Prandase; drug class: at an early stage can not only prevent type II (adult-onset) diabetes from developing but can also drastically dras·tic adj. 1. Severe or radical in nature; extreme: the drastic measure of amputating the entire leg; drastic social change brought about by the French Revolution. 2. lower the risk of cardiovascular complications such as myocardial infarction myocardial infarction: see under infarction. . These findings of the large-scale international STOP-NIDDM STOP-NIDDM Study to Prevent Non-Insulin-Dependent Diabetes Mellitus Study were recently presented at the 21st International Bayer Pharma Press Seminar in Munich. You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?7865 This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics and photos. If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion